New Auranofin Analogs with Antibacterial Properties against Burkholderia Clinical Isolates.
Ontology highlight
ABSTRACT: Bacteria of the genus Burkholderia include pathogenic Burkholderia mallei, Burkholderia pseudomallei and the Burkholderia cepacia complex (Bcc). These Gram-negative pathogens have intrinsic drug resistance, which makes treatment of infections difficult. Bcc affects individuals with cystic fibrosis (CF) and the species B. cenocepacia is associated with one of the worst clinical outcomes. Following the repurposing of auranofin as an antibacterial against Gram-positive bacteria, we previously synthetized auranofin analogs with activity against Gram-negatives. In this work, we show that two auranofin analogs, MS-40S and MS-40, have antibiotic activity against Burkholderia clinical isolates. The compounds are bactericidal against B. cenocepacia and kill stationary-phase cells and persisters wit
SUBMITTER: Maydaniuk D
PROVIDER: S-EPMC8697972 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA